RxDoctor Payments Data

Albert Edwards, MD

Family Medicine · Powder Springs, GANPI 1265505531

Payments from drug & device makers

$3,378in general payments, 2019–2025

Across 34 payments — averaging $99.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Novo Nordisk$987
  • Intuitive Surgical$591
  • Lilly USA, LLC$95
  • GSK$85
  • Tonix Medicines, Inc.$84
  • plus $109 from 2 others

What the payments were for

  • Travel & lodging$59117%
  • Food & beverage$2,78182%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca17$1,427
Novo Nordisk10$987
Intuitive Surgical2$591
Lilly USA, LLC1$95
GSK1$85
Tonix Medicines, Inc.1$84
Scilex Pharmaceuticals Inc.1$57
Kaleo, Inc.1$53

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,378 in reported general payments places this provider in the 75th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$48,707
Medicare patients
95
Services billed
463

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide108$114,088
FarxigaDapagliflozin Propanediol99$92,872
TrulicityDulaglutide76$89,500
MounjaroTirzepatide44$56,002
EliquisApixaban31$30,154
JardianceEmpagliflozin28$25,164
Bydureon BciseExenatide Microspheres16$22,721
Trelegy ElliptaFluticasone/Umeclidin/Vilanter34$21,653
Emgality PenGalcanezumab-Gnlm19$21,119
LinzessLinaclotide18$18,906
JanuviaSitagliptin Phosphate21$17,834
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen347$13,024
EntrestoSacubitril/Valsartan12$12,771
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen324$11,955
RybelsusSemaglutide11$10,243

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$95$145,501120 claims
Novo NordiskOzempic, Rybelsus$987$124,331119 claims
AstraZenecaFarxiga$1,427$92,87299 claims
GSKTrelegy Ellipta$85$21,65334 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Powder Springs

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →